Related Experiment Video
Updated: Aug 6, 2026

07:17
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Oncological problems in pancreatic cancer surgery
Akimasa Nakao1, Tsutomu Fujii, Hiroyuki Sugimoto
1Department of Surgery II, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. nakaoaki@med.nagoya-u.ac.jp
World Journal of Gastroenterology
|July 29, 2006
Summary
Early detection of pancreatic cancer remains challenging. While surgical resection offers the best survival chance, poor prognosis persists due to metastasis and recurrence, highlighting key surgical oncology problems.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Pancreatic carcinoma often presents at advanced stages, limiting curative treatment options.
- Despite advances in surgical techniques and increased resection rates, postoperative outcomes remain poor.
- Metastasis, recurrence, and peritoneal dissemination are common challenges following pancreatic cancer surgery.
Purpose of the Study:
- To review current challenges in pancreatic cancer surgery.
- To discuss recent molecular-biological findings relevant to pancreatic cancer.
- To address oncological problems in the surgical management of pancreatic cancer.
Main Methods:
- Review of recent literature on pancreatic cancer diagnosis and treatment.
- Analysis of molecular-biological studies on metastasis and systemic disease.
- Discussion of surgical techniques and postoperative prognosis.
Main Results:
- Early detection of pancreatic cancer remains a significant clinical challenge.
- Surgical resection is the only curative option, but is often performed at late stages.
- Postoperative prognosis is frequently poor due to liver metastasis, local recurrence, and peritoneal dissemination.
Conclusions:
- Advances in surgical techniques have improved resection rates but not overall survival.
- Molecular-biological insights into occult and micrometastasis are crucial for understanding disease progression.
- Addressing systemic disease and metastasis is critical for improving outcomes in pancreatic cancer surgery.